Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)

Abroad (travel likely)Recruiting

Conditions

Interstitial Lung Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic, Rochester, Minnesota, United States
Contact: Study coordinator (Michael Stachowitz) · Stachowitz.Michael@mayo.edu · 507-284-4862
Contact: Principal Investigator (Eva Carmona, M.D., Ph.D.)

Study leads

Eva M Carmona Porquera, MD, PhD
Principal Investigator
Mayo Clinic

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease

Fibrotic Interstitial Lung Disease

Abroad (travel likely)RecruitingPHASE2

Edmonton, Canada

Breathlessness Perceptions Within Respiratory Diseases

Chronic Obstructive Pulmonary Disease (COPD) · Asthma (Diagnosis) · Interstitial Lung Disease (ILD)

Abroad (travel likely)Recruiting

Leicester, United Kingdom

Skeletal Muscle Function in Interstitial Lung Disease

Interstitial Lung Disease · Idiopathic Pulmonary Fibrosis · Hypersensitivity Pneumonitis

Abroad (travel likely)Recruiting

Vancouver, Canada

Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease

Pulmonary Fibrosis, Interstitial Lung Disease · Idiopathic Pulmonary Fibrosis

Abroad (travel likely)RecruitingPHASE2

Aarhus N, Denmark · Copenhagen, Denmark